From PK/PD to QSP: Understanding the Dynamic Effect of Cholesterol-Lowering Drugs on Atherosclerosis Progression and Stratified Medicine

Author(s): Cesar Pichardo-Almarza, Vanessa Diaz-Zuccarini

Journal Name: Current Pharmaceutical Design

Volume 22 , Issue 46 , 2016

Become EABM
Become Reviewer
Call for Editor


Current computational and mathematical tools are demonstrating the high value of using systems modeling approaches (e.g. Quantitative Systems Pharmacology) to understand the effect of a given compound on the biological and physiological mechanisms related to a specific disease. This review provides a short survey of the evolution of the mathematical approaches used to understand the effect of particular cholesterol-lowering drugs, from pharmaco-kinetic (PK) / pharmaco-dynamic (PD) models, through physiologically base pharmacokinetic models (PBPK) to QSP. These mathematical models introduce more mechanistic information related to the effect of these drugs on atherosclerosis progression and demonstrate how QSP could open new ways for stratified medicine in this field.

Keywords: Quantitative Systems Pharmacology (QSP), cholesterol-lowering drugs, statins, atherosclerosis, mathematical modeling, simulation, personalized medicine.

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Published on: 23 January, 2017
Page: [6903 - 6910]
Pages: 8
DOI: 10.2174/1381612822666160905095402

Article Metrics

PDF: 69
PRC: 1